Source: Annual Congress 2003 - Lung cancer management
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. P. Zarogoulidis, N. E. Galanis, B. Georgoulias, A. Xafenias, P. Panousis, E. Kalaitzidou, C. Kourousis, N. Androulakis, T. N. Kontakiotis (Thessaloniki, Heraclion, Greece). Is the current staging system realistic for SCLC?. Eur Respir J 2003; 22: Suppl. 45, 308

Member's Comments

No comment yet.

Related content which might interest you: A new classification system for NSCLC: what do we expect from imaging? Source: Annual Congress 2009 - The new classification system of nonsmall cell lung cancer: a challenge for imaging Year: 2009 Modern staging in lung cancer: from the current multidisciplinary process to novel approaches Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Comparison of the new and current TNM staging system in bronchoplastic resection for non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010 A proposal in small cell lung cancer staging according to TNM system Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 PET-CT, NSCLC staging and surgery: an audit of current experience Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Staging and restaging in the era of multimodality treatment Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006 PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines Source: Annual Congress 2010 - State of the art imaging Year: 2010 Use and limitations of TNM-based staging in lung cancer, assessed by current and new imaging procedures Source: Annual Congress 2013 –PG2 Imaging in the management of thoracic malignancies Year: 2013 From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 An algorithm for lung cancer staging Source: School Course 2014- Endoscopic ultrasound in the diagnosing and staging of lung cancer Year: 2014 The new TNM classification of lung cancer in practice Source: Breathe 2011; 7: 348-360 Year: 2011 Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer Source: Eur Respir J 2013; 42: 1119-1133 Year: 2013 Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the radiotherapist Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Eminence or evidence based ? – personalised diagnostic-therapeutic sequences in a molecular altered advanced NSCLC patient Source: International Congress 2017 – GR2 Lung Cancer Grand Round Year: 2017 Is EBUS sampling adequate for molecular testing in patients with advanced NSCLC? Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020 Can IASLC/ATS/ERS subtype help predict response to chemotherapy in small biopsies of advanced lung adenocarcinoma? Source: Eur Respir J 2014; 43: 1240-1242 Year: 2014 Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives Source: Eur Respir Rev 2011; 20: 45-52 Year: 2011